[Home]   [Full version]  

Yeast behind potentially deadly infections tackled by multi million pound collaboration

Nov 27 ,General Science



Full size image
How yeast infections fight off multiple attacks from the human immune system is the subject of a new study awarded £4.6 million today. The team of internationally renowned scientists receiving the grant hope their findings could pave the way for better and more effective anti-fungal drugs.

Researchers will make use of an exciting new approach to life sciences research called systems biology. By combining researchers from biological, physical and computational disciplines, this offers a much more powerful and efficient way of studying complex biological problems.

The project will focus on the yeasts Candida albicans and Candida glabrata which live in our bodies and are usually kept in check by our immune systems. But if the yeast is not reined-in it can grow and cause infections such as thrush which is suffered by most women at some point in their lives. In general, this is easily treated with anti-fungal therapies.

However, out-of-control Candida can be life threatening in people with weakened immune systems such as cancer patients and those who have had transplants. Candida infections are a relatively common cause of bloodstream infections among some patient groups with severe immune deficiencies and about 30-40%of those cases can be fatal.

Now thanks to funding from the Biotechnology and Biological Sciences Research Council (BBSRC), researchers from the University of Aberdeen and Imperial College London are about to embark on an entirely new approach to investigating the organism.

Biologists, mathematicians, statisticians and computer scientists are joining forces to spend the next five years exploring in detail the daily battles our bodies have with these members of the fungal family.

Up until now, research in this field has examined how Candida reacts to single steps taken by our immune systems to fend off the fungus. Now for the first time scientists will look at how Candida fights for its life against multiple counter measures taken by our bodies to try to kill it off. They are able map the defence mechanisms of the fungi in this way by using state-of-the-art computational modelling.

Professor Al Brown, Chair in Molecular and Cell Biology at the University of Aberdeen and Director of the project, said: "This is a tremendously exciting interdisciplinary research project which aims to understand how these medically important fungal pathogens protect themselves against attack from our immune systems.

"Our research should dramatically advance our understanding of these organisms and, in the longer term, this should contribute to the development of more effective antifungal therapies.

"The project represents a revolution in the way that we approach biological systems in which organisms are subject to combinations of many different stimuli. This is the case for most real biological situations, and hence the methods that we develop will be relevant to many other important biological problems."

Mathematician Professor Jaroslav Stark, Director of the BBSRC/EPSRC Centre for Integrative Systems Biology at Imperial College, added: "The exciting thing about this project is the opportunity that Systems Biology offers for scientists from many different disciplines to contribute to biological problems that are important to our society. Working in such an interdisciplinary team is very stimulating, since each discipline has different insights and different perspectives. When these are combined we have the possibility of creating radically new approaches to the study of biological systems. It's an incredibly exciting way in which to apply mathematics!"

Professors Brown and Stark lead a team of international experts in Candida biology and computational modelling from the University of Aberdeen and Imperial College London.

The experimental biologists include Professor Neil Gow and Dr Ken Haynes. The modellers include Professors Celso Grebogi and Michael Stumpf, and Drs George Coghill, Alessandro Moura, Marco Thiel and Maria Carmen Romano.

The funding also enables the hiring of four new researchers at each institution, and the training of four post-graduate students.

Source: University of Aberdeen

Related stories:

New Search Engine Can be Used for Creative Discovery
When you ask a supercomputer to tell a story, you might not expect a creative outcome – or any. But a group of Virginia Tech researchers are using System X, the university’s supercomputer, to test a new search program that can tell the stories of life – the connections between gene sets, for instance, or the connections between discoveries reported in biomedical articles on the U.S. National Library of Medicine PubMed database.
Researcher converts biodiesel-waste glycerol into omega-3 fatty acids
The typical American diet often lacks omega-3 fatty acids despite clinical research that shows their potential human health benefits. Zhiyou Wen, assistant professor of biological systems engineering in Virginia Tech's College of Agriculture and Life Sciences, found a way to grow these compounds using a byproduct of the emerging biodiesel industry.
Accumulated bits of a cell's own DNA can trigger autoimmune disease
A security system wired within every cell to detect the presence of rogue viral DNA can sometimes go awry, triggering an autoimmune response to single-stranded bits of the cell's own DNA, according to a report in the August 22nd issue of the journal Cell, a Cell Press publication. The source of that single-stranded DNA is so-called endogenous retroelements—genetic elements accounting for a substantial portion of the genome that can move to new locations using a "copy and paste" mechanism, according to the researchers.
RV Polarstern on its way to East Siberian Sea
Bremerhaven, August 19th 2008. German research vessel Polarstern, operated by the Alfred Wegener Institute for Polar and Marine Research in the Helmholtz Association, transits the Northwest Passage for the first time. Polarstern left the port of Reykjavik on August 12th, sailed around Greenland on a southern course and is located right in the Northwest Passage. Its destination is the East Siberian Sea where geoscientific measurements at the junction between the Mendeleev Ridge and the East Siberian Shelf are at the focus of the participants of this expedition. The measurements striven for in the framework of the International Polar Year shall help to understand how the undersea ridges and basins were built. This expedition takes the researchers in 68 days around the North Pole because the return voyage is to lead via the Northeast Passage.
Catalyst mystery unlocked
Different keys are not supposed to fit the same lock, but in biological systems multiple versions of a catalyst all make a reaction go, according to a new study that explains the phenomenon. Scheduled for online publication in PNAS Early Edition sometime after Aug. 18, the study challenges entrenched ideas about the workings of catalysts.
Caltech researchers awarded $10M for molecular programming project
The National Science Foundation's Expeditions in Computing program has awarded $10 million to the Molecular Programming Project, a collaborative effort by researchers at the California Institute of Technology and the University of Washington to establish a fundamental approach to the design of complex molecular and chemical systems based on the principles of computer science.
Gel undergoes Peristalsis
(PhysOrg.com) -- Large or small, machine parts only move when controlled by an external impulse. Biological systems, on the other hand, are capable of autonomous movements that continuously follow their own rhythms and spatial patterns. For example, intestinal peristalsis—a circular, constricting, unidirectional muscular contraction—depends in part on an inherent muscular rhythm.
Engineers build mini drug-producing biofactories in yeast
Researchers at the California Institute of Technology have developed a novel way to churn out large quantities of drugs, including antiplaque toothpaste additives, antibiotics, nicotine, and even morphine, using mini biofactories--in yeast.

News discussion:

General Science news

[Home]   [Full version]